PPARG and cystic fibrosis: In vitro, they showed that hMSC decreased pro-inflammatory cytokine production in LPS-stimulated mouse bone marrow-derived macrophages or human peripheral blood mononuclear cells, and upregulate the expression of PPARγ, which is an important regulator of inflammation in chronic inflammatory diseases such as CF [122,123].